1349PSubsequent therapies post-afatinib among patients...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1349PSubsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7

Sequist, L., Wu, Y-L., Schuler, M., Kato, T., Yang, J.C-H., Tanaka, H., Hida, T., Lu, S., Park, K., Laurie, S., Bennouna, J., Moro Sibilot, D., Märten, A., Peil, B., Ehrnrooth, E., Yamamoto, N., Nakag
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.051
Date:
September, 2017
File:
PDF, 67 KB
english, 2017
Conversion to is in progress
Conversion to is failed